Clinical trial
Phase I Trial of Paclitaxel With Perifosine
NCT00399126 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00399126 |
|---|---|
| Title | Phase I Trial of Paclitaxel With Perifosine |
| Official title | A Phase 1 Trial of the Combination of Perifosine and Paclitaxel Given Either Weekly or Every 3 Weeks |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Perifosine, Paclitaxel |
| Enrollment | 24 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Oct 1, 2011 |
| First posted | Nov 14, 2006 |
| Last update posted | Feb 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: